The drug of choice for persistent unstable ventricular arrhythmia is –
**Core Concept**
The question is testing the knowledge of pharmacological management of ventricular arrhythmias. **Ventricular arrhythmias** are abnormal heart rhythms originating from the ventricles, and **persistent unstable ventricular arrhythmia** requires immediate pharmacological intervention to prevent cardiac arrest or sudden death.
**Why the Correct Answer is Right**
The drug of choice for persistent unstable ventricular arrhythmia is **Lidocaine**. Lidocaine is a class Ib anti-arrhythmic medication that works by blocking sodium channels, which decreases the automaticity of the cardiac myocytes and thus suppresses ventricular arrhythmias. **Lidocaine is particularly effective in treating ventricular tachycardia and ventricular fibrillation**. It has a rapid onset of action and is often administered intravenously in acute settings.
**Why Each Wrong Option is Incorrect**
**Option A:** **Phenytoin** is another anti-arrhythmic medication but is not the first-line treatment for persistent unstable ventricular arrhythmia. **Phenytoin has a slower onset of action and is associated with more side effects** compared to lidocaine.
**Option B:** **Amiodarone** is a class III anti-arrhythmic medication used in the treatment of various types of arrhythmias, including ventricular arrhythmias. However, **amiodarone is generally reserved for more stable or chronic arrhythmias** and is not the preferred initial treatment for persistent unstable ventricular arrhythmia.
**Option C:** **Adenosine** is a medication used to treat supraventricular tachycardia, not ventricular arrhythmias. **Adenosine works by transiently blocking AV node conduction**, which is not relevant to the treatment of ventricular arrhythmias.
**Clinical Pearl / High-Yield Fact**
In the management of ventricular arrhythmias, it's essential to remember that **Lidocaine is the drug of choice for acute, unstable ventricular arrhythmias**. Always consider the patient's hemodynamic stability and the severity of the arrhythmia when selecting an anti-arrhythmic medication.
**Correct Answer:** C. Amiodarone.